MedPath
TGA Approval

XELEVIA sitagliptin (as phosphate monohydrate) 25 mg film-coated tablet blister pack (408440)

408440

XELEVIA sitagliptin (as phosphate monohydrate) 25 mg film-coated tablet blister pack

Merck Sharp & Dohme (Australia) Pty Ltd

August 2, 2023

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/7b87d5503a84eb96f17a8ed8bf7e6498.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/5b6e49b8a845921669921f86f0878dd2.pdf

Active Ingredients

sitagliptin phosphate monohydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

XELEVIA sitagliptin (as phosphate monohydrate) 25 mg film-coated tablet blister pack (408440) - TGA 批准文号 | MedPath